ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

PRI, Fending Off More Giants, Reportedly wins New operations. Support contract at Frederick

July 10, 1987

NCI Community Intervention Trial Reports

March 10, 1995

American Cancer Society Awards $51.4 million in research grants

April 15, 2011

IVAX And It’s Portfolio

December 22, 1994

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

April 2, 1976

ASPO Honors Gritz.

May 25, 2001